Becton, Dickinson and Company BDXB NYSE

Becton, Dickinson and Company (BDXB) reported total assets of $55.33B and total liabilities of $29.94B for fiscal year 2025, resulting in total equity of $25.39B.

The company held $859M in cash and short-term investments. Total debt stood at $19.18B, with net debt of $18.33B. The Debt-to-Equity (D/E) ratio was 0.76 (moderate).

Current ratio is 1.11, suggesting adequate short-term liquidity. Interest coverage is 4.2x (adequate).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (73/100) — Total assets $55.33B and equity $25.39B support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.76 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 64/100 with 3/7 criteria passed.

BSX-PA

Boston Scientific Corporation

$122.18

+2.37%

BHFAP

Brighthouse Financial, Inc.

$16.43

+1.23%

BHFAO

Brighthouse Financial, Inc.

$16.98

+1.49%

BHFAN

Brighthouse Financial, Inc.

$13.39

+0.45%

AEPPZ

American Electric Power Company, Inc.

$47.12

-1.09%

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%